Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| L-(-)-Fucose | 1g Pack Size. Group: Sugars. Formula: C6H12O5. CAS No. 2438-80-4. Prepack ID : 90028077-1g. Molecular Weight : 164.16. |  |
| L-(-)-Fucose | L-(-)-Fucose. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 2438-80-4. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. |  Cenik Chemicals |
| 2-Deoxy-2-fluoro-L-fucose | 2-Deoxy-2-fluoro-L-fucose, an indispensable compound in the biomedical sector, finds diverse therapeutic applications. Its pivotal role lies in the development of pharmaceutical agents combating ailments like cancer, inflammation, and viral infections. Group: Pharmaceutical. Alternative Names: 2,6-dideoxy-2-fluoro-L-Galactose. CAS No. 70763-62-1. Pack Sizes: 100 mg. Product ID: B1370-225495. Molecular formula: C6H11FO4. Mole weight: 166.15. Custom synthesis is available. Send your inquiries for more information. |  London |
| GDP-L-fucose | GDP-L-fucose is a pivotal biomolecule acting as a precursory compound to facilitate the synthesis of fucose-containing glycoconjugates implicated in diverse cellular phenomena. Its exceptional significance lies in the research of glycosylation patterns, evaluation of protein functioning repercussions and investigation into possible therapeutic approaches targeting conditions like cancer and inflammation. Group: Pharmaceutical. Alternative Names: GDP-b-L-fucose; Guanosine 5-diphospho-b-L-fucose; GDP-Fucose; Guanosine diphosphofucose; Guanosine 5'-diphospho-beta-L-fucopyranose; guanosine 5'-[3-(6-deoxy-beta-L-galactopyranosyl) dihydrogen diphosphate]. CAS No. 15839-70-0. Pack Sizes: 50 mg. Product ID: B1370-168219. Molecular formula: C16H25N5O15P2. Mole weight: 589.34. Custom synthesis is available. Send your inquiries for more information. | London |
| GDP-L-fucose disodium salt | Substrate for fucosyltransferase. Group: Pharmaceutical. Alternative Names: Guanosine 5'-pyrophosphate, β-L-fucopyranosyl ester Disodium Salt; Guanosine pyrophosphate, L-fucosyl ester Disodium Salt; Guanosine diphosphofucose Disodium Salt; Guanosine diphosphate fucose Disodium Salt; Guanosine 5'-pyrophosphate, L-fucosyl ester Disodium Salt; Guanosine 5'-diphospho-β-L-fucose Disodium Salt; GDP-Fucose Disodium Salt. CAS No. 148296-47-3. Pack Sizes: 5 mg. Product ID: B2706-339907. Molecular formula: C16H23N5O15P2Na2. Mole weight: 633.31. Custom synthesis is available. Send your inquiries for more information. | London |
| A1F N-Glycan | A1F N-Glycan, the versatile biomolecule employed by the biomedical industry, is the key player in the in-depth scrutiny and diagnosis of diverse disorders - think cancer, Alzheimer's, and rheumatoid arthritis. Its multifaceted involvement in cell signaling pathways has made it a go-to diagnostic marker in countless clinical settings. Furthermore, the therapeutic potential of A1F N-Glycan has not gone unexploited; it forms the crux of several drug formulations aimed at combating these afflictions. Group: Pharmaceutical. Alternative Names: Monosialo (2,6), fucosylated biantennary (A1F); A1F glycan; FA2G2S1 Glycan; Mono-sialylated, galactosylated, core-fucosylated, bi-antennary N-linked glycan; Mannotriose-(fucosyl-di-[N-acetylglucosamine]), mono-sialyl-bis(galactosyl-N-acetylglucosaminyl); NeuNAc(Gal-GlcNAc)2Man3(GlcNAc)2Fuc; β-D-Glucopyranose, O-(N-acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-[1→3(or 1→6)]-O-[O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-[1→6(or 1→3)]]-O-β-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-. CAS No. 571188-30-2. Pack Sizes: 1mg;1g;10g. Produc | London |
| A2FB N-Glycan | A2FB N-Glycan is an indispensable compound in the biomedical field, playing a significant role in elucidating and deciphering the intricate N-glycosylation profiles discernible in diverse pharmaceuticals and ailments. Group: Pharmaceutical. Alternative Names: sialyl, fucosylated, bisected biantennary N-linked glycan. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information. | London |
| A2F N-Glycan | A2F N-Glycan is a biomolecule widely found in human cells, involved in glycosylation process. It is commonly used in the biomedicine industry for studying age-related macular degeneration (AMD) as well as other diseases related to glycation, such as Alzheimer's and diabetes. A2F N-Glycan also plays a crucial role in developing therapeutic drugs targeted to these diseases. Group: Pharmaceutical. Alternative Names: Disialo, galactosylated, fucosylated, biantennary (A2F); Di-sialylated, galactosylated, core-fucosylated bi-antennary N-linked glycan; FA2G2S2 Glycan; Mannotriose-(fucosyl-di-[N-acetylglucosamine]), bis(sialyl-galactosyl-N-acetylglucosaminyl); (NeuNAc-Gal-GlcNAc)2Man2(Fuc)(GlcNAc)2; A2F glycan; O-(N-Acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-(1→3)-O-[O-(N-acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-O-β-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-D-glucose. CAS No. 108341-22-6. Pack Sizes: 1mg;1g;10g. Product ID: 108341-22-6. Molecular formula: C90H148N6O66. Mole weight: 2370.14. Custom synthesis is available. S | London |
| Saikosaponin A | Saikosaponin A, a triterpenoid glycoside, induces apoptotic mechansims in human breast cancer cell lines. It also displays an inhibitory activity against allergic asthma. It mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. It as antioxidants improve antioxidant status. Uses: Anti-inflammatory agents, non-steroidal. Group: Pharmaceutical. Alternative Names: (3b,4a,16b)-13,28-Epoxy-16,23-dihydroxyolean-11-en-3-yl 3-O-b-D-glucopyranosyl-b-D-fucoside; (3β,4α,16β)-13,28-Epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galactopyranoside; Salikosaponin A. CAS No. 20736-09-8. Pack Sizes: 20 mg. Product ID: NP7012. Molecular formula: C42H68O13. Mole weight: 780.98. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
